NON-INVASIVE TUMOR IMAGING BY TUMOR-TARGETED BACTERIA

摘要

The present invention provides non-invasive compositions and methods to dete ct solid tumors using tumor-targeted bacteria. specifically, the present invention provides compositions and methods for detecting solid tumors in vi vo by delivery of a marker gene to a solid tumor via a population of tumor- targeted bacteria, methods for detecting solid tumors by detecting a compoun d incorporated into the bacteria, methods for detecting solid tumors by detecting an infection caused by the bacteria at the tumor site(s), methods for detecting solid tumors by detecting an antigen present on the surface of the bacterial vectors. When detecting a tumor entails detecting a marker gen e product expressed by the tumor-targeted bacteria, the marker gene product ca n be detected directly in the tumor, by the use of a labeled moiety that interacts with the marker gene product, or by the use of the labeled marker substrate. Thus, if a marker gene product is directly detectable, it can be detected directly. When a marker gene product is not directly detectable, a labeled moiety that interacts with the marker gene product is detected, or a labeled marker substrate is used and a labeled marker metabolite is detected . A tumor can thus be localized or detected by scanning a subject to detect th e marker gene product,a labeled complex comprising the marker gene product and its interacting moiety, or a labeled marker metabolite, respectively, thereb y imaging the tumor. Specifically, the attenuated tumor-targeted bacteria of t he invention are facultative aerobes or facultative anaerobes which are modifie d to encode the marker gene. Still further, this invention provides compositio ns and methods of simultaneously imaging and treating a tumor in a subject usin g one or a plurality of populations tumor-targeted organisms. The invention provides non-invasive, clinically applicable methods for imaging tumors whic h can be implemented using existing imaging techniques to monitor and evaluate in vivo cancer treatments in human subjects. Kits are also provided.